From Pittsburgh, Pennsylvania, USA:
My mother has type 2 diabetes. Her diabetes doctor wants her to take Monopril [an ACE inhibitor] to control kidney protein levels, but her primary physician says the Monopril is causing her blood pressure to go too low and told her to stop taking it. She told each doctor what the other said, but neither wants to change his position. She has no idea who is right or what she should do. What would you suggest?
This is a fairly common clinical problem. Monopril is used not only to lower blood pressure but as an agent that protects the kidneys from continued injury and loss of function with most kidney diseases, including diabetes-induced kidney disease.
If your mother is having problems with low pressure, it should be backed off to lowest tolerated dose. If no dose is tolerated, the Monopril should be stopped. Fortunately, there are other agents that have similar benefits. They are known as angiotensin II receptor antagonists. They might be better tolerated because their blood pressure-lowering potential is not as great as the class that includes Monopril, a class known as ACE inhibitors.
It should be added that clear indications for the use of drugs that prevent kidney disease progression exist. They include high blood pressure greater than 130/80 and increased urine microalbumin. If no elevated blood pressure or increased albumin in the urine exist, it is controversial whether ACE inhibitors or angiotensin II receptor antagonists should be used prophylactically.
|Return to the Top of This Page|
Last Updated: (none)
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.